Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines Research Letter
| Authors: | Zhang, J.; Wang, T.; Shetty, K.; Alkan, S.; Xu, S.; Gong, Q.; Liu, X.; Li, Y.; Hu, Z.; Huang, W.; Wendel, H. G.; Herrera, A. F.; Pillai, R. K.; Song, J. Y.; Chan, W. C. |
| Title: | Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines |
| Keywords: | clinical article; controlled study; unclassified drug; human cell; drug efficacy; nonhuman; flow cytometry; antineoplastic agent; letter; polymerase chain reaction; mouse; animal tissue; gene; gene targeting; bortezomib; gene expression; animal experiment; animal model; drug effect; drug mechanism; drug response; immunophenotyping; clinical effectiveness; genetic risk; drug sensitivity; oncogene myc; bcl2 gene; lymphoma cell line; silvestrol; ibrutinib; human; male; dactolisib; nod scid gamma mouse; venetoclax; 4 (4 chlorophenyl) 2,3,9 trimethyl 6h thieno[3,2 f][1,2,4]triazolo[4,3 a][1,4]diazepine 6 acetic acid tert butyl ester; dinaciclib; pi3k gene; 10074 g5; btk gene; cdk gene; coh dhl1 cell line; coh thl1 cell line |
| Journal Title: | Blood Advances |
| Volume: | 6 |
| Issue: | 17 |
| ISSN: | 2473-9529 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-09-13 |
| Start Page: | 5067 |
| End Page: | 5071 |
| Language: | English |
| DOI: | 10.1182/bloodadvances.2021006709 |
| PUBMED: | 35687491 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 November 2022 -- Source: Scopus |
